John T. Henderson, Director at MYRIAD GENETICS INC (MYGN), sold 30,000 shares at $44.00 ($1.3M) on 2018-07-11, disclosed to the SEC on 2018-07-13.
Open-market sale of $1.3M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.17 | 10,000 | $402K | 31.8% |
| 2 | $42.01 | 10,000 | $420K | 33.3% |
| 3 | $44.00 | 10,000 | $440K | 34.9% |
| Total | $42.06 avg | 30,000 | $1.3M | 100% |
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |